HIV meds to re­main on pre­ferred sta­tus with Med­i­caid

GA Voice - - News Briefs -

All sin­gle-pill HIV reg­i­mens will re­main on pre­ferred sta­tus with Med­i­caid. This news comes af­ter State Sen. Vin­cent Fort (D-At­lanta) and sev­eral LGBT rights groups called on the Ge­or­gia Depart­ment of Com­mu­nity Health (DCH) to re­con­sider a pro­posed move that would down­grade sev­eral HIV med­i­ca­tions from pre­ferred sta­tus on its Med­i­caid for­mu­lary. The change would have left only one sin­gle-pill daily HIV med­i­ca­tion, Atripla, un­der pre­ferred sta­tus, although pa­tients cur­rently tak­ing the other once-daily reg­i­mens would have the op­tion of be­ing grand­fa­thered in.

Sen. Fort sent a let­ter to DCH Com­mis­sioner Clyde Reese on Aug. 15 voic­ing his ob­jec­tions to the pro­posed change, cit­ing sev­eral sta­tis­tics on HIV/AIDS med­i­ca­tions and say­ing, “I urge you to re­con­sider your pro­posal for the sake of public health. This change could prove to be dis­as­trous and could set our state back in the fight against HIV/AIDS.”

In a con­ver­sa­tion with Ge­or­gia Voice, Com­mis­sioner Reece’s of­fice con­firmed that the change would be re­flected on DCH’s web­site pend­ing an up­date.

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.